CAMP4 Therapeutics Corp (CAMP) PT Raised to $9 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Mani Foroohar raised the price target on CAMP4 Therapeutics Corp (NASDAQ: CAMP) to $9.00 (from $8.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
